Casteràs Anna, Fidilio Enzamaria, Comas Marta, Zabalegui Alba, Flores Vanesa, Giralt Marina, Díaz-Troyano Noelia, Ferrer Roser, Vilallonga Ramon, Ciudin Andreea, Biagetti Betina
Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron 119-121, 08035 Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
J Clin Med. 2024 Aug 30;13(17):5146. doi: 10.3390/jcm13175146.
Bariatric surgery (BS) is effective for achieving significant weight loss. However, weight regain (WR) is an emerging problem. To assess the prognostic value of morning serum cortisol, a 1 mg dexamethasone suppression test (DST), 24 h urinary free cortisol (UFC) and late-night salivary cortisol (LNSC) in a cohort of patients with severe obesity (pwSO) undergoing BS in terms of weight loss and WR. Patients scheduled for BS underwent the following procedures at baseline, 12 months and 24 months after BS: medical history, anthropometric data, blood analysis and cortisol tests. We evaluated total weight loss (TWL) ≥ 30% at 1 year and WR after 2 years as an increase of ≥10% of the maximum weight lost. : In total, 142 subjects were included; 101 (71.1%) were females and the mean age was 45.9 ± 9.2 years. Up to 76.8% of subjects achieved ≥30% TWL, without statistically significant differences in DST results or morning serum cortisol, UFC or LNSC levels. However, a higher pre-surgery morning serum cortisol level was a significant predictor of a WR ≥ 10% (cortisol 17.8 [IQR 13.1-18.5] vs. 12.0 [IQR 8.8-15.8] μg/dL; < 0.01); OR of 1.216 (95% CI 1.069-1.384); AUC [0.761, CI: (0.616-0.906); < 0.01]. A cut-off value of cortisol > 13.0 μg/dL was predictive of a WR ≥ 10% (sensitivity 0.71; specificity 0.63). No cortisol test was useful in predicting weight loss; however, the pre-surgery morning serum cortisol level was able to predict a WR ≥ 10% in a cohort of pwSO 2 years after BS. A cut-off value of cortisol > 13 μg/dL might be an easy tool to identify patients at higher risk of WR, enabling healthcare providers to implement tailored, long-term strategies to minimize this outcome.
减肥手术(BS)对于实现显著体重减轻是有效的。然而,体重反弹(WR)是一个新出现的问题。为了评估早晨血清皮质醇、1毫克地塞米松抑制试验(DST)、24小时尿游离皮质醇(UFC)和深夜唾液皮质醇(LNSC)在一组接受BS的重度肥胖患者(pwSO)中对体重减轻和WR的预后价值。计划接受BS的患者在基线、BS后12个月和24个月接受了以下检查:病史、人体测量数据、血液分析和皮质醇检测。我们将1年时总体重减轻(TWL)≥30%以及2年后WR定义为体重减轻最大值增加≥10%。总共纳入了142名受试者;其中101名(71.1%)为女性,平均年龄为45.9±9.2岁。高达76.8%的受试者实现了≥30%的TWL,DST结果或早晨血清皮质醇、UFC或LNSC水平无统计学显著差异。然而,术前较高的早晨血清皮质醇水平是WR≥10%的显著预测因素(皮质醇17.8 [四分位间距13.1 - 18.5] 与12.0 [四分位间距8.8 - 15.8] μg/dL;<0.01);比值比为1.216(95%置信区间1.069 - 1.384);曲线下面积[0.761,置信区间:(0.616 - 0.906);<0.01]。皮质醇>13.0 μg/dL的临界值可预测WR≥10%(敏感性0.71;特异性0.63)。没有皮质醇检测对预测体重减轻有用;然而,术前早晨血清皮质醇水平能够在BS后2年的pwSO队列中预测WR≥10%。皮质醇>13 μg/dL的临界值可能是一种简单的工具,用于识别WR风险较高的患者,使医疗保健提供者能够实施量身定制的长期策略,以尽量减少这种结果。